Abstract
Xenotransplantation is the attempt to use living biological material from nonhuman animal species in humans for therapeutic purposes. Clinical trials and preclinical studies have suggested that living cells and tissue from other species have the potential to be used in humans to ameliorate disease. However, the potential for successful xenotransplantation to cure human disease is coupled with the risk that therapeutic use of living nonhuman cells in humans may also serve to introduce xenogeneic infections of unpredictable significance. Animal husbandry practices and xenotransplantation product preparation may eliminate most exogenous infectious agents prior to transplantation. However, endogenous retroviruses are present in the genomes of all mammalian cells, have an inadequately defined ability to infect human cells, and have generated public health concern. The history of xenotransplantation, the implications for public health, the global consensus on public safeguards necessary to accompany clinical trials, and the future direction of xenotransplantation are discussed in the context of public health. Mt Sinai J Med 76:435–441, 2009. © 2009 Mount Sinai School of Medicine
Keywords: porcine endogenous virus, public health, xenogeneic infections, xenotransplantation
REFERENCES
- 1. United States Public Health Service . Public health service guideline on infectious disease issues in xenotransplantation. MMWR Recomm Rep 2001; 50: 1–46. [PubMed] [Google Scholar]
- 2. Chapman LE, Bloom ET. Clinical xenotransplantation. JAMA 2001; 285: 2304–2306. [DOI] [PubMed] [Google Scholar]
- 3. Boneva, R. , Folks TM, Chapman LE. Infectious disease issues associated with xenotransplantation. Clin Microbiol Rev 2001; 14: 1–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.United Network for Organ Sharing. Available at: http://www.unos.org. Accessed June 2009.
- 5. Starzl TE, Fung J, Tzakis A, et al. Baboon to human transplantation. Lancet 1993; 341: 65–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Gaines BA, Colson YL, Kaufman CL, Ildstad ST. Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients. Exp Hematol 1996; 24: 902–913. [PubMed] [Google Scholar]
- 7. Ilstad ST. Xenotransplantation for AIDS. Lancet 1996; 347: 761. [DOI] [PubMed] [Google Scholar]
- 8. Chapman LE, Salomon DR, Patterson AP, et al. Xenotransplantation and xenogeneic infections. N Engl J Med 1995; 333: 1498–1501. [DOI] [PubMed] [Google Scholar]
- 9. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre‐diabetes in the U.S. population in 1988–1994 and 2005–2006. Diabetes Care 2009; 32: 287–294. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Minshall ME, Roze S, Palmer AJ, et al. Treating diabetes to accepted standards of care: a 10‐year projection of these estimated economic and health impact in patients with type 1 and type 2 diabetes mellitus in the United States. Clin Ther 2005; 27: 940–950. [DOI] [PubMed] [Google Scholar]
- 11. Chapman LE, Khabbaz RF. Review: etiology and epidemiology of the Four Corners hantavirus outbreak. Infect Agents Dis 1994; 3: 234–244. [PubMed] [Google Scholar]
- 12. Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349: 1236–1245. [DOI] [PubMed] [Google Scholar]
- 13. Vana G, Westover KM. Origin of the 1918 Spanish influenza virus: a comparative genomic analysis. Mol Phylogenet Evol 2008; 47: 1100–1110. [DOI] [PubMed] [Google Scholar]
- 14. Hahn BH, Shaw GM, De Cock KM, et al. AIDS as a zoonosis: scientific and public health implications. Science 2000; 287: 607–614. [DOI] [PubMed] [Google Scholar]
- 15. Xenotransplantation: Guidance on Infectious Disease Prevention and Management. Geneva, Switzerland: World Health Organization; 1998; WHO document WHO/EMC/ZOO/98.1. [Google Scholar]
- 16. Mahy BWJ. The Dictionary of Virology. 4th ed. London, United Kingdom: Academic Press; 2009; 407. [Google Scholar]
- 17. Brown J, Matthews L, Sandstrom PA, Chapman LE. Xenotransplantation and the risk of retroviral zoonosis. Trends Microbiol 1998; 6: 411–415. [DOI] [PubMed] [Google Scholar]
- 18. Chapman LE, Switzer WM, Sandstrom PA, et al. Infectious disease issues in xenotransplantation In: Scheld WM, Craig WA, Hughes JM, eds. Emerging Infections 3. Washington, DC: ASM Press; 1999. [Google Scholar]
- 19. Bloom, ET. Xenotransplantation—Federal Regulatory Considerations In: Salomon DR, Wilson C, eds. Current Topics in Microbiology: Xenotransplantation. Berlin: Springer‐Verlag; 2003; 239–251. [PubMed] [Google Scholar]
- 20. US Food and Drug Administration . Draft guidance for industry: precautionary measures to reduce the possible risk of transmission of zoonoses by blood and blood products from xenotransplantation product recipients and their contacts. Available at: http://www.fda.gov/biologicsbloodvaccines/guidancecomplianceregulatoryinformation/guidances/blood/ucm075125.htm. Accessed June 2009.
- 21. Heneine W. Strategies for diagnosis of xenotransplant‐associated retroviral infections. Mol Diagn 1996; 1: 255–260. [DOI] [PubMed] [Google Scholar]
- 22. Heneine W, Switzer WM. Highly sensitive and specific polymerase chain reaction assays for detection of baboon and pig cells following xenotransplantation in humans. Transplantation 1996; 62: 1360–1362. [DOI] [PubMed] [Google Scholar]
- 23. Patience C, Patton GS, Takeuchi Y, et al. No evidence of pig DNA or retroviral infection in patients with short‐term extracorporeal connection to pig kidneys. Lancet 1998; 352: 699–701. [DOI] [PubMed] [Google Scholar]
- 24. Heneine W, Tibell A, Switzer WM, et al. No evidence of infection with the porcine endogenous retrovirus in human recipients of porcine islet cell xenografts. Lancet 1998; 352: 695–699. [DOI] [PubMed] [Google Scholar]
- 25. Paradis K, Langford G, Long Z, et al. Search for cross species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science 1999; 285: 1236–1241. [DOI] [PubMed] [Google Scholar]
- 26. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci 1996; 93: 705–708. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Chapman LE. Xenotransplantation In: Burroughs T, Knobler S, Lederberg J, eds. The Emergence of Zoonotic Diseases: Understanding the Impact on Animal and Human Health. Washington, DC: National Academy Press; 2001; 17–20. [PubMed] [Google Scholar]
- 28. Chapman LE, Wilson CA. Commentary: implications of the advent of homozygous α1,3‐galactosyltransferase gene‐deficient pigs on transmission of infectious agents. Xenotransplantation 2003; 10: 287–288. [DOI] [PubMed] [Google Scholar]
- 29. Nyberg SL, Hibbs JJR, Hardin JA, et al. Transfer of porcine endogenous retrovirus across hollow fiber membranes: significance to a bio‐artificial liver. Transplantation 1999; 67: 1251–1255. [DOI] [PubMed] [Google Scholar]
- 30. Quri SH, Magre S, Garcia‐Lerma JG, et al. Susceptibility of the porcine endogenous retroviruses to reverse transcriptase and protease inhibitors. J Virol 2001; 75: 1048–1053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Simeonovic CJ, Ziolkowski AF, Popp SK, et al. Porcine endogenous retrovirus encodes xenoantigens involved in porcine cellular xenograft rejection by mice. Transplantation 2005; 79: 1674–1682. [DOI] [PubMed] [Google Scholar]